Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 106€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  2. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  3. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  4. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  5. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  6. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  7. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  8. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  9. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  10. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  11. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  12. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  13. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  14. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  15. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  16. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  17. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  18. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  19. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  20. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  21. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  22. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  23. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  24. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  25. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  26. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  27. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  28. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  29. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  30. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  31. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  32. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  33. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  34. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  35. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  36. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  37. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  38. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  39. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  40. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  41. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  42. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  43. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  44. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  45. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  46. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  47. Poli V, et al. 2021. iScience. 24:103256. PubMed
  48. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  49. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  50. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  51. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  52. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  53. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  54. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  55. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  56. Chen S, et al. 2022. Cancer Discov. :. PubMed
  57. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  58. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  59. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  60. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  61. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  62. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  63. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  64. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  65. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  66. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  67. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  68. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  69. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  70. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  71. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  72. Li B, et al. 2022. iScience. 25:103772. PubMed
  73. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  74. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  75. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  76. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  77. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  78. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  79. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  80. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  81. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  82. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  83. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  84. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  85. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  86. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  87. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  88. Kasper M, et al. 2021. Elife. 10:. PubMed
  89. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  90. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  91. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  92. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  93. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  94. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  95. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  96. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  97. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  98. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  99. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  100. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  101. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  102. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  103. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  104. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  105. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  106. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  107. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  108. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  109. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  110. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  111. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  112. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  113. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  114. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  115. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  116. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  117. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  118. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  119. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  120. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  121. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  122. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  123. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  124. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  125. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  126. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  127. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  128. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  129. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  130. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  131. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  132. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  133. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  134. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  135. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  136. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  137. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  138. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  139. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  140. Gao H, et al. 2021. Cells. 10:. PubMed
  141. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  142. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  143. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  144. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  145. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  146. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  147. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  148. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  149. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  150. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  151. Köchl R, et al. 2020. Elife. 9:00. PubMed
  152. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  153. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  154. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  155. Dong S, et al. 2021. Nature. 591:117. PubMed
  156. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  157. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  158. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  159. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  160. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  161. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  162. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  163. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  164. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  165. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  166. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  167. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  168. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  169. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  170. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  171. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  172. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  173. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  174. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  175. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  176. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  177. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  178. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  179. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  180. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  181. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  182. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  183. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  184. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  185. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  186. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  187. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  188. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  189. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  190. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  191. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  192. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  193. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  194. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  195. Cho K, et al. 2021. iScience. 24:103117. PubMed
  196. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  197. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  198. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  199. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  200. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  201. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  202. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  203. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  204. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  205. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  206. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  207. Dong L, et al. 2022. Cells. 11:. PubMed
  208. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  209. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  210. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  211. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  212. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  213. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  214. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  215. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  216. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  217. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  218. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  219. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  220. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  221. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  222. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  223. Liu P, et al. 2022. iScience. 25:103867. PubMed
  224. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  225. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  226. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  227. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  228. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  229. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  230. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  231. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  232. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  233. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  234. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  235. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  236. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  237. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  238. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  239. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  240. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  241. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  242. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  243. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  244. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  245. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  246. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  247. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  248. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  249. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  250. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  251. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  252. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  253. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  254. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  255. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  256. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  257. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  258. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  259. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  260. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  261. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  262. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  263. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  264. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  265. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  266. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  267. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  268. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  269. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  270. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  271. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  272. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  273. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  274. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  275. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  276. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  277. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  278. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  279. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  280. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  281. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  282. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  283. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  284. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  285. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  286. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  287. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  288. Tang S, et al. 2022. Virol J. 19:32. PubMed
  289. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  290. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  291. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  292. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  293. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  294. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  295. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  296. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  297. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  298. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  299. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  300. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  301. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  302. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  303. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  304. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  305. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  306. Wang X, et al. 2022. Elife. 11:. PubMed
  307. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  308. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  309. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  310. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  311. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  312. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  313. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  314. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  315. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  316. Liu SS, et al. 2021. Immunity. :. PubMed
  317. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  318. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  319. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  320. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  321. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  322. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  323. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  324. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  325. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  326. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  327. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  328. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  329. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  330. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  331. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  332. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  333. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  334. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  335. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  336. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  337. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  338. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  339. Wang S, et al. 2022. Blood. 140:171. PubMed
  340. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  341. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  342. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  343. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  344. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  345. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  346. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  347. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  348. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  349. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  350. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  351. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  352. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11-30-2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account